Cargando…
Selective inhibition of the p38α MAPK–MK2 axis inhibits inflammatory cues including inflammasome priming signals
p38α activation of multiple effectors may underlie the failure of global p38α inhibitors in clinical trials. A unique inhibitor (CDD-450) was developed that selectively blocked p38α activation of the proinflammatory kinase MK2 while sparing p38α activation of PRAK and ATF2. Next, the hypothesis that...
Autores principales: | Wang, Chun, Hockerman, Susan, Jacobsen, E. Jon, Alippe, Yael, Selness, Shaun R., Hope, Heidi R., Hirsch, Jeffrey L., Mnich, Stephen J., Saabye, Matthew J., Hood, William F., Bonar, Sheri L., Abu-Amer, Yousef, Haimovich, Ariela, Hoffman, Hal M., Monahan, Joseph B., Mbalaviele, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940269/ https://www.ncbi.nlm.nih.gov/pubmed/29549113 http://dx.doi.org/10.1084/jem.20172063 |
Ejemplares similares
-
Omnipresence of inflammasome activities in inflammatory bone diseases
por: Alippe, Yael, et al.
Publicado: (2019) -
Poly-ADP-ribosylation-mediated degradation of ARTD1 by the NLRP3 inflammasome is a prerequisite for osteoclast maturation
por: Wang, C, et al.
Publicado: (2016) -
IκB-ζ signaling promotes chondrocyte inflammatory phenotype, senescence, and erosive joint pathology
por: Arra, Manoj, et al.
Publicado: (2022) -
Chronic inflammation triggered by the NLRP3 inflammasome in myeloid cells promotes growth plate dysplasia by mesenchymal cells
por: Wang, Chun, et al.
Publicado: (2017) -
Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation
por: Alippe, Yael, et al.
Publicado: (2017)